Skip to main content
SpringerLink
Log in

Autismus-Spektrum-Störungen

  • Chapter
  • First Online:
Book cover Neuro-/Psychopharmaka im Kindes- und Jugendalter

Zusammenfassung

Psychopharmakologische Ansätze bei Autismus-Spektrum-Störungen sind aktuell vor allem darauf gerichtet, bestimmte, teilweise auch nur komorbide, auftretende Verhaltensweisen oder zusätzliche psychische Störungen zu verbessern. Es gibt einzelne Versuche, die zentrale autistische Symptomatik im Bereich der sozialen Interaktion, Kommunikation, Sprache und auch vor allem im Bereich des stereotypen Verhaltens zu verbessern. Dies ist aktuell erfolgreich nur bezüglich des stereotypen Verhaltens gelungen. In dem folgenden Kapitel sind deshalb differenziell Psychopharmaka aufgeführt, die bestimmte Zielsymptome bei Autismus-Spektrum-Störungen verbessern. Dabei wurde überwiegend auf Psychopharmaka rekurriert, die einen Evidenzgrad von II und besser aufweisen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Abramson RK, Wright HH, Carpenter R et al (1989) Elevated blood serotonin in autistic probands and their first-degree relatives. J Autism Dev Disord 19:397–407

    Article  CAS  PubMed  Google Scholar 

  • Abramson R, Ravan S, Wright H et al (2005) The relationship between restrictive and repetitive behaviors in individuals with autism and obsessive compulsive symptoms in parents. Child Psychiatry Hum Dev 36:155–165

    Article  CAS  PubMed  Google Scholar 

  • Adams JB, Audhya T, McDonough-Means S et al (2011) Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr 11:111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Albertini G, Polito E, Sara M, Di GG, Onorati P (2006) Compulsive masturbation in infantile autism treated by mirtazapine. Pediatr Neurol 34:417–418

    Article  PubMed  Google Scholar 

  • Aman MG, Arnold LE, McDougle CJ et al (2005) Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol 15:869–884

    Article  PubMed  Google Scholar 

  • Aman MG, Hollway JA, McDougle CJ et al (2008) Cognitive effects of risperidone in children with autism and irritable behavior. J Child AdolescPsychopharmacol 18:227–236

    Article  PubMed  PubMed Central  Google Scholar 

  • Aman MG, McDougle CJ, Scahill L et al (2009) Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. J Am Acad Child Adolesc Psychiatry 48:1143–1154

    Article  PubMed  Google Scholar 

  • Amiet C, Gourfinkel-An I, Laurent C et al (2013) Does epilepsy in multiplex autism pedigrees define a different subgroup in terms of clinical characteristics and genetic risk? Mol Autism 4:47

    Article  PubMed  PubMed Central  Google Scholar 

  • Amminger GP, Berger GE, Schafer MR, Klier C, Friedrich MH, Feucht M (2007) Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry 61:551–553

    Article  CAS  PubMed  Google Scholar 

  • Anagnostou E, Chaplin W, Watner D et al (2011) Factor analysis of repetitive behaviors in autism as measured by the Y-BOCS. J Neuropsychiatry Clin Neurosci 23:332–339

    Article  PubMed  Google Scholar 

  • Anderson LT, Campbell M, Grega DM, Perry R, Small AM, Green WH (1984) Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms. Am J Psychiatry 141:1195–1202

    Article  CAS  PubMed  Google Scholar 

  • Anderson LT, Campbell M, Adams P, Small AM, Perry R, Shell J (1989) The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. J Autism Dev Disord 19:227–239

    Article  CAS  PubMed  Google Scholar 

  • Arnold LE, Aman MG, Cook AM et al (2006) Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry 45:1196–1205

    Article  PubMed  Google Scholar 

  • Baird G, Simonoff E, Pickles A et al (2006) Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 368:210–215

    Article  PubMed  Google Scholar 

  • Baron-Cohen S, Scott FJ, Allison C et al (2009) Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psychiatry 194:500–509

    Article  PubMed  Google Scholar 

  • Belsito KM, Law PA, Kirk KS, Landa RJ, Zimmerman AW (2001) Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord 31:175–181

    Article  CAS  PubMed  Google Scholar 

  • Berg JM, Geschwind DH (2012) Autism genetics: searching for specificity and convergence. Genome Biol 13:247

    Article  PubMed  PubMed Central  Google Scholar 

  • Berry-Kravis EM, Hessl D, Rathmell B, Zarevics P, Cherubini M, Walton-Bowen K et al (2012) Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial. SciTranslMed 4:152ra127

    Article  PubMed  CAS  Google Scholar 

  • Brugha TS, McManus S, Bankart J et al (2011) Epidemiology of autism spectrum disorders in adults in the community in England. Arch Gen Psychiatry 68:459–465

    Article  PubMed  Google Scholar 

  • Campbell M, Anderson LT, Small AM, Locascio JJ, Lynch NS, Choroco MC (1990) Naltrexone in autistic children: a double-blind and placebo-controlled study. Psychopharmacol Bull 26:130–135

    CAS  PubMed  Google Scholar 

  • Campbell M, Anderson LT, Small AM, Adams P, Gonzalez NM, Ernst M (1993) Naltrexone in autistic children: behavioral symptoms and attentional learning. J Am Acad Child Adolesc Psychiatry 32:1283–1291

    Article  CAS  PubMed  Google Scholar 

  • Chez MG, Burton Q, Dowling T, Chang M, Khanna P, Kramer C (2007) Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability. J Child Neurol 22:574–579

    Article  PubMed  Google Scholar 

  • Cooper B (2003) Evidence-based mental health policy: a critical appraisal. BrJ Psychiatry 183:105–113

    Article  PubMed  Google Scholar 

  • Corson AH, Barkenbus JE, Posey DJ, Stigler KA, McDougle CJ (2004) A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders. J Clin Psychiatry 65:1531–1536

    Article  CAS  PubMed  Google Scholar 

  • Cortesi F, Giannotti F, Sebastiani T, Panunzi S, Valente D (2012) Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial. J Sleep Res 21:700–709

    Article  PubMed  Google Scholar 

  • Coskun M, Karakoc S, Kircelli F, Mukaddes NM (2009) Effectiveness of mirtazapine in the treatment of inappropriate sexual behaviors in individuals with autistic disorder. J Child Adolesc Psychopharmacol 19:203–206

    Article  PubMed  Google Scholar 

  • Couturier JL, Speechley KN, Steele M, Norman R, Stringer B, Nicolson R (2005) Parental perception of sleep problems in children of normal intelligence with pervasive developmental disorders: prevalence, severity, and pattern. J Am Acad Child Adolesc Psychiatry 44:815–822

    Article  PubMed  Google Scholar 

  • Cubells JF, Deoreo EH, Harvey et al (2011) Pharmaco-genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndrome. Am J Med Genet A 155A:805–810

    Article  PubMed  CAS  Google Scholar 

  • Dadds MR, Macdonald E, Cauchi A, Williams K, Levy F, Brennan J (2014) Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial. J Autism Dev Disord 44:521–531

    Article  PubMed  Google Scholar 

  • Dilling H, Mombour W, Schmidt MH (Hrsg) (2013) Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien, 9. Aufl. Huber, Bern

    Google Scholar 

  • Doyle CA, McDougle CJ (2012) Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan. Dialogues Clin Neurosci 14:263–279

    PubMed  PubMed Central  Google Scholar 

  • Erickson CA, Posey DJ, Stigler KA, Mullett J, Katschke AR, McDougle CJ (2007) A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl) 191:141–147

    Article  CAS  Google Scholar 

  • Falkai P, Wittchen H-U (Hrsg) (2015) American Psychiatric Association. Diagnostisches und Statistisches Manual Psychischer Störungen DSM-5®. Hogrefe, Göttingen

    Google Scholar 

  • Findling RL, Mankoski R, Timko K et al (2014) A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder. J Clin Psychiatry 75:22–30

    Article  CAS  PubMed  Google Scholar 

  • Freitag CM (2010) Empirically based early intervention programs for children with autistic disorders – a selective literature review. Z Kinder Jugendpsychiatr Psychother 38:247–256

    Article  PubMed  Google Scholar 

  • Freitag CM (2011) Genetic risk in autism: new associations and clinical testing. Expert Opin Med Diagn 5:347–356

    Article  PubMed  Google Scholar 

  • Freitag CM (2012) Autistic disorders – the state of the art and recent findings: epidemiology, aetiology, diagnostic criteria, and therapeutic interventions. Z Kinder Jugendpsychiatr Psychother 40:139–149

    Article  PubMed  Google Scholar 

  • Freitag CM, Cholemkery H, Elsuni L et al (2013) The group-based social skills training SOSTA-FRA in children and adolescents with high functioning autism spectrum disorder – study protocol of the randomised, multi-centre controlled SOSTA-net trial. Trials 14:6

    Article  PubMed  PubMed Central  Google Scholar 

  • Freitag CM, Cholemkery H, Elsuni L (2014) Das Autismus-spezifische soziale Kompetenztraining SOSTA-FRA für Kinder und Jugendliche mit Autismus-Spektrum-Störung – Prä-Post-Effekte. Kindheit Entwicklung 23:52–60

    Article  Google Scholar 

  • Frye RE, Melnyk S, Macfabe DF (2013) Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder. Transl Psychiatry 3:e220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ghaleiha A, Ghyasvand M, Mohammadi MR et al (2013) Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial. J Psychopharmacol 28:677–685

    Article  PubMed  CAS  Google Scholar 

  • Ghaziuddin M, Tsai L (1991) Depression in autistic disorder. Br J Psychiatry 159:721–723

    Article  CAS  PubMed  Google Scholar 

  • Ghaziuddin M, Tsai L, Ghaziuddin N (1991) Fluoxetine in autism with depression. J Am Acad Child Adolesc Psychiatry 30:508–509

    Article  CAS  PubMed  Google Scholar 

  • Ghaziuddin M, Ghaziuddin N, Greden J (2002) Depression in persons with autism: implications for research and clinical care. J Autism Dev Disord 32:299–306

    Article  PubMed  Google Scholar 

  • Golubchik P, Sever J, Weizman A (2013) Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive/hyperactive symptoms: an open-label trial. Clin Neuropharmacol 36:37–41

    Article  CAS  PubMed  Google Scholar 

  • Gordon CT, State RC, Nelson JE, Hamburger SD, Rapoport JL (1993) A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry 50:441–447

    Article  CAS  PubMed  Google Scholar 

  • Guastella AJ, Gray KM, Rinehart NJ et al (2015) The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial. J Child Psychol Psychiatry 56(4):444–452

    Article  PubMed  Google Scholar 

  • Hagerman RJ (2006) Lessons from fragile X regarding neurobiology, autism, and neurodegeneration. J Dev Behav Pediatr 27:63–74

    Article  PubMed  Google Scholar 

  • Hardan AY, Jou R, Handen BL (2005) Retrospective study of quetiapine in children and adolescents with pervasive developmental disorders. J Autism Dev Disord 35:387–391

    Article  PubMed  Google Scholar 

  • Hardan AY, Fung LK et al (2012) A randomized controlled pilot trial of oral N-acetylcysteine in children with autism. Biol Psychiatry 71:956–961

    Article  CAS  PubMed  Google Scholar 

  • Harfterkamp M, Loo-Neus G, Minderaa RB et al (2012) A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 51:733–741

    Article  PubMed  Google Scholar 

  • Harfterkamp M, Buitelaar JK, Minderaa RB, Loo-Neus G, van der Gaag RJ, Hoekstra PJ (2013) Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study. J Child Adolesc Psychopharmacol 23:194–199

    Article  CAS  PubMed  Google Scholar 

  • Hellings JA, Weckbaugh M, Nickel EJ et al (2005) A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. J Child Adolesc Psychopharmacol 15:682–692

    Article  PubMed  Google Scholar 

  • Hirota T, Veenstra-VanderWeele J, Hollander E, Kishi T (2014) Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis. J Autism Dev Disord 44:948–957

    Article  PubMed  Google Scholar 

  • Hollander E, Anagnostou E, Chaplin W et al (2005) Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biol Psychiatry 58:226–232

    Article  PubMed  Google Scholar 

  • Hollander E, Wasserman S, Swanson EN et al (2006) A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. J Child Adolesc Psychopharmacol 16:541–548

    Article  PubMed  Google Scholar 

  • Hollander E, Chaplin W, Soorya L et al (2010) Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology 35:990–998

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hollander E, Soorya L, Chaplin W et al (2012) A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. Am J Psychiatry 169:292–299

    Article  PubMed  Google Scholar 

  • Hurwitz R, Blackmore R, Hazell P, Williams K, Woolfenden S (2012) Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents. Cochrane Database Syst Rev 3:CD008372

    PubMed  Google Scholar 

  • Ibrahim SH, Voigt RG, Katusic SK, Weaver AL, Barbaresi WJ (2009) Incidence of gastrointestinal symptoms in children with autism: a population-based study. Pediatrics 124:680–686

    Article  PubMed  PubMed Central  Google Scholar 

  • Jesner OS, Aref-Adib M, Coren E (2007) Risperidone for autism spectrum disorder. Cochrane Database Syst Rev CD005040

    Google Scholar 

  • Kielinen M, Rantala H, Timonen E, Linna SL, Moilanen I (2004) Associated medical disorders and disabilities in children with autistic disorder: a population-based study. Autism 8:49–60

    Article  PubMed  Google Scholar 

  • Kim Y, Cho SC, Shin MS, Kim JW, Lee SH, Kim BN (2010) Retrospective case series of aripiprazole augmentation in pervasive developmental disorders. Psychiatry Investig 7:220–223

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • King BH, Wright DM, Handen BL et al (2001) Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. J Am Acad Child Adolesc Psychiatry 40:658–665

    Article  CAS  PubMed  Google Scholar 

  • King BH, Hollander E, Sikich L et al (2009) Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry 66:583–590

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kitzerow J, Wilker C, Teufel K et al (2014) Das Frankfurter Frühinterventionsprogramm (FFIP) für Vorschulkinder mit Autismus-Spektrum-Störungen (ASS): Erste Ergebnisse zur Sprachentwicklung. Kindheit Entwicklung 23:34–41

    Article  Google Scholar 

  • Kolevzon A, Newcorn JH, Kryzak L et al (2010) Relationship between whole blood serotonin and repetitive behaviors in autism. Psychiatry Res 175:274–276

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Krakowiak P, Goodlin-Jones B, Hertz-Picciotto I, Croen LA, Hansen RL (2008) Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study. J Sleep Res 17:197–206

    Article  PubMed  PubMed Central  Google Scholar 

  • Krishnaswami S, McPheeters ML, Veenstra-VanderWeele J (2011) A systematic review of secretin for children with autism spectrum disorders. Pediatrics 127:e1322–e1325

    Article  PubMed  PubMed Central  Google Scholar 

  • Langen M, Schnack HG, Nederveen H et al (2009) Changes in the developmental trajectories of striatum in autism. Biol Psychiatry 66:327–333

    Article  PubMed  Google Scholar 

  • Langen M, Leemans A, Johnston P et al (2012) Fronto-striatal circuitry and inhibitory control in autism: findings from diffusion tensor imaging tractography. Cortex 48:183–193

    Article  PubMed  Google Scholar 

  • Leigh MJ, Nguyen DV, Mu Y et al (2013) A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome. J Dev Behav Pediatr 34:147–155

    Article  PubMed  PubMed Central  Google Scholar 

  • Leyfer OT, Folstein SE, Bacalman S et al (2006) Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord 36:849–861

    Article  PubMed  Google Scholar 

  • Malone RP, Delaney MA, Hyman SB, Cater JR (2007) Ziprasidone in adolescents with autism: an open-label pilot study. J Child Adolesc Psychopharmacol 17:779–790

    Article  PubMed  Google Scholar 

  • Malow BA, Byars K, Johnson K et al (2012) A practice pathway for the identification, evaluation, and management of insomnia in children and adolescents with autism spectrum disorders. Pediatrics 130(Suppl 2):S106–S124

    Article  PubMed  Google Scholar 

  • Marcus RN, Owen R, Kamen L et al (2009) A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 48:1110–1119

    Article  PubMed  Google Scholar 

  • McCracken JT, McGough J, Shah B et al (2002) Risperidone in children with autism and serious behavioral problems. N Engl J Med 347:314–321

    Article  CAS  PubMed  Google Scholar 

  • McDougle CJ, Kem DL, Posey DJ (2002) Case series: use of ziprasidone for maladaptive symptoms in youths with autism. J Am Acad Child Adolesc Psychiatry 41:921–927

    Article  PubMed  Google Scholar 

  • McDougle CJ, Scahill L, Aman MG et al (2005) Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry 162:1142–1148

    Article  PubMed  Google Scholar 

  • Mehlinger R, Scheftner WA, Poznanski E (1990) Fluoxetine and autism. J Am Acad Child Adolesc Psychiatry 29:985

    Article  CAS  PubMed  Google Scholar 

  • Mouridsen SE, Rich B, Isager T (2011a) A longitudinal study of epilepsy and other central nervous system diseases in individuals with and without a history of infantile autism. Brain Dev 33:361–366

    Article  PubMed  Google Scholar 

  • Mouridsen SE, Rich B, Isager T (2011b) Epilepsy and other central nervous system diseases in atypical autism: a case control study. J Neural Transm 118:621–627

    Article  PubMed  Google Scholar 

  • Mouridsen SE, Rich B, Isager T (2013) Epilepsy in individuals with a history of Asperger’s syndrome: A Danish nationwide register-based cohort study. J Autism Dev Disord 43:1308–1313

    Article  PubMed  Google Scholar 

  • Namerow L, Thomas P, Bostic JQ, Prince J, Monuteaux MC (2003) Use of citalopram in pervasive developmental disorders. J Dev Behav Pediatr 24:104–108

    Article  PubMed  Google Scholar 

  • Nguyen M, Murphy T (2001) Mirtazapine for excessive masturbation in an adolescent with autism. J Am Acad Child Adolesc Psychiatry 40:868–869

    Article  CAS  PubMed  Google Scholar 

  • Nicolson R, Craven-Thuss B, Smith J (2006) A prospective, open-label trial of galantamine in autistic disorder. J Child Adolesc Psychopharmacol 16:621–629

    Article  PubMed  Google Scholar 

  • Niederhofer H, Staffen W, Mair A (2002) Galantamine may be effective in treating autistic disorder. BMJ 325:1422

    Article  PubMed  PubMed Central  Google Scholar 

  • Nye C, Brice A (2005) Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database Syst Rev CD003497

    Google Scholar 

  • Ospina MB, Krebs SJ, Clark B et al (2008) Behavioural and developmental interventions for autism spectrum disorder: a. clinical systematic review PLoSONE 3:e3755

    Article  PubMed  CAS  Google Scholar 

  • Owen R, Sikich L, Marcus RN et al (2009) Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 124:1533–1540

    Article  PubMed  Google Scholar 

  • Owley T, Salt J, Guter S et al (2006) A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders. J Child Adolesc Psychopharmacol 16:517–524

    Article  PubMed  Google Scholar 

  • Posey DJ, Guenin KD, Kohn AE, Swiezy NB, McDougle CJ (2001) A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders. J Child Adolesc Psychopharmacol 11:267–277

    Article  CAS  PubMed  Google Scholar 

  • Posey DJ, Kem DL, Swiezy NB, Sweeten TL, Wiegand RE, McDougle CJ (2004) A pilot study of D-cycloserine in subjects with autistic disorder. Am J Psychiatry 161:2115–2117

    Article  PubMed  Google Scholar 

  • Posey DJ, Aman MG, McCracken JT et al (2007) Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry 61:538–544

    Article  CAS  PubMed  Google Scholar 

  • Rapin I, Tuchman RF (2008) Autism: definition, neurobiology, screening, diagnosis. Pediatr Clin North Am 55:1129–1146 (viii)

    Article  PubMed  Google Scholar 

  • Reddy KS (2005) Cytogenetic abnormalities and fragile-X syndrome in autism spectrum disorder. BMC Med Genet 6:3–19

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Reichow B, Volkmar FR, Cicchetti DV (2008) Development of the evaluative method for evaluating and determining evidence-based practices in autism. J Autism Dev Disord 38:1311–1319

    Article  PubMed  Google Scholar 

  • Reichow B, Volkmar FR, Bloch MH (2013) Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders. J Autism Dev Disord 43(10):2435–2541

    Article  PubMed  PubMed Central  Google Scholar 

  • Remington G, Sloman L, Konstantareas M, Parker K, Gow R (2001) Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study. J Clin Psychopharmacol 21:440–444

    Article  CAS  PubMed  Google Scholar 

  • Research Units on Pediatric Psychopharmacology Autism Network (2005) Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 62:1266–1274

    Article  Google Scholar 

  • Rossignol DA, Frye RE (2011) Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol 53:783–792

    Article  PubMed  Google Scholar 

  • Rueda JR, Ballesteros J, Guillen V, Tejada MI, Sola I (2011) Folic acid for fragile X syndrome. Cochrane Database SystRev CD008476

    Google Scholar 

  • Russell AJ, Mataix-Cols D, Anson M, Murphy DG (2005) Obsessions and compulsions in Asperger syndrome and high-functioning autism. Br J Psychiatry 186:525–528

    Article  PubMed  Google Scholar 

  • Russell AJ, Jassi A, Fullana MA et al (2013) Cognitive behavior therapy for comorbid obsessive-compulsive disorder in high-functioning autism spectrum disorders: a randomized controlled trial. Depress Anxiety 30(8):697–708

    Article  PubMed  Google Scholar 

  • Sharma A, Shaw SR (2012) Efficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: a meta-analysis. J Pediatr Health Care 26:291–299

    Article  PubMed  Google Scholar 

  • Shea S, Turgay A, Carroll A et al (2004) Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 114:e634–e641

    Article  PubMed  Google Scholar 

  • Siegel M (2012) Psychopharmacology of autism spectrum disorder: evidence and practice. Child Adolesc Psychiatr Clin N Am 21:957–973

    Article  PubMed  Google Scholar 

  • Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G (2008) Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry 47:921–929

    Article  PubMed  Google Scholar 

  • Steingard RJ, Zimnitzky B, DeMaso DR, Bauman ML, Bucci JP (1997) Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder. J Child Adolesc Psychopharmacol 7:9–15

    Article  CAS  PubMed  Google Scholar 

  • Storch EA, Arnold EB, Lewin AB et al (2013) The effect of cognitive-behavioral therapy versus treatment as usual for anxiety in children with autism spectrum disorders: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 52:132–142

    Article  PubMed  Google Scholar 

  • Torrioli MG, Vernacotola S, Peruzzi L et al (2008) A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys. Am J Med Genet A 146:803–812

    Article  Google Scholar 

  • Van Renynghe de Voxvrie G, De Bie M (1976) Character neuroses and behavioural disorders in children: their treatment with pipamperone (Dipiperon). A clinical study. Acta Psychiatr Belg 76:688–695

    CAS  PubMed  Google Scholar 

  • Wasserman S, Iyengar R, Chaplin WF et al (2006) Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study. Int Clin Psychopharmacol 21:363–367

    Article  PubMed  Google Scholar 

  • White SW, Albano AM, Johnson CR et al (2010) Development of a cognitive-behavioral intervention program to treat anxiety and social deficits in teens with high-functioning autism. Clin Child Fam Psychol Rev 13:77–90

    Article  PubMed  PubMed Central  Google Scholar 

  • Williams E, Thomas K, Sidebotham H, Emond A (2008) Prevalence and characteristics of autistic spectrum disorders in the ALSPAC cohort. Dev Med Child Neurol 50:672–677

    Article  PubMed  Google Scholar 

  • Williams K, Brignell A, Randall M, Silove N, Hazell P (2013) Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev 8:CD004677

    PubMed  Google Scholar 

  • Zandt F, Prior M, Kyrios M (2007) Repetitive behaviour in children with high functioning autism and obsessive compulsive disorder. J Autism Dev Disord 37:251–259

    Article  PubMed  Google Scholar 

  • Zimmer MH, Hart LC, Manning-Court P, Murray DS, Bing NM, Summer S (2012) Food variety as a predictor of nutritional status among children with autism. J Autism Dev Disord 42:549–556

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters, Universitätsklinikum Frankfurt, Deutschordenstraße 50, 60528, Frankfurt, Deutschland

    Prof. Dr. med. Christine Freitag & Dr. med. Tomasz Jarczok

Authors
  1. Prof. Dr. med. Christine Freitag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. med. Tomasz Jarczok
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christine Freitag .

Editor information

Editors and Affiliations

  1. Zentrum für Seelische Gesundheit, Universitätsklinikum Würzburg, Würzburg, Germany

    Manfred Gerlach

  2. Privatklinik für Seelische Gesundheit, J, HEMERA Klinik, Bad Kissingen, Germany

    Claudia Mehler-Wex

  3. Zentrum für Kinder- und Jugendpsychiatri, Universität Zürich, Zürich, Zürich, Switzerland

    Susanne Walitza

  4. Zentrum für Seelische Gesundheit, Universitätsklinikum Würzburg, Würzburg, Bayern, Germany

    Andreas Warnke

  5. Abteilung Kinder Jugendpsychiatrie, Kliniken der Stadt Köln gGmbH, Köln, Germany

    Christoph Wewetzer

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Freitag, C., Jarczok, T. (2016). Autismus-Spektrum-Störungen. In: Gerlach, M., Mehler-Wex, C., Walitza, S., Warnke, A., Wewetzer, C. (eds) Neuro-/Psychopharmaka im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48624-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-48624-5_13

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-48623-8

  • Online ISBN: 978-3-662-48624-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation